Inspire Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
612
+165
+37% +$169K 0.05% 288
2026
Q1
$411K Buy
447
+223
+100% +$226K 0.03% 405
2025
Q4
$241K Buy
+224
New +$214K 0.02% 450
2024
Q1
Sell
-407
Closed -$237K 402
2023
Q4
$237K Sell
407
-13
-3% -$7.59K 0.04% 265
2023
Q3
$226K Buy
+420
New +$216K 0.04% 241

Other funds holding LLY

Inspire Advisors's LLY Position: Q2 2026 in Review

Inspire Advisors increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $169K and bringing the position to 612 shares worth $733K. The position accounts for 0.05% of the portfolio, ranked #288.

Inspire Advisors first reported a position in LLY in Q3 2023 and has held it in 5 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Inspire Advisors held 612 shares of Eli Lilly worth $733K as of Q2 2026.
  • Inspire Advisors bought 165 Eli Lilly shares in Q2 2026, an estimated $169K.
  • Eli Lilly made up 0.05% of Inspire Advisors's portfolio in Q2 2026, its #288 holding.
  • Inspire Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 5 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.